During the last session, T2 Biosystems Inc (NASDAQ:TTOO)’s traded shares were 0.84 million, with the beta value of the company hitting 0.38. At the end of the trading day, the stock’s price was $0.41, reflecting an intraday gain of 2.50% or $0.01. The 52-week high for the TTOO share is $6.95, that puts it down -1595.12 from that peak though still a striking 24.39% gain since the share price plummeted to a 52-week low of $0.31. The company’s market capitalization is $8.63M, and the average intraday trading volume over the past 10 days was 0.84 million shares, and the average trade volume was 875.71K shares over the past three months.
T2 Biosystems Inc (NASDAQ:TTOO) trade information
The stock spiked 2.50% in intraday trading to $0.41, hitting a weekly high. The stock’s 5-day price performance is 0.00%, and it has moved by -22.96% in 30 days. Based on these gigs, the overall price performance for the year is -93.31%. The short interest in T2 Biosystems Inc (NASDAQ:TTOO) is 0.83 million shares and it means that shorts have 1.26 day(s) to cover.
The consensus price target of analysts on Wall Street is $5, which implies an increase of 91.8% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $5 and $5 respectively. As a result, TTOO is trading at a discount of -1119.51% off the target high and -1119.51% off the low.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 68.62%.
TTOO Dividends
T2 Biosystems Inc is due to release its next quarterly earnings in February. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
T2 Biosystems Inc (NASDAQ:TTOO)’s Major holders
T2 Biosystems Inc insiders own 10.17% of total outstanding shares while institutional holders control 73.51%, with the float percentage being 81.83%.